NACDS: Senate Finance Committee Work is Essential to "Real" PBM Reform at the Federal Level

NACDS is urging ongoing bipartisan work for Americans on Medicare and Medicaid and for their pharmacies - and is calling on the U.S. Congress to stand strong amid predictable and misleading PBM attacks.

ARLINGTON, Va., Nov. 7, 2023 /PRNewswire-PRWeb/ -- With the U.S. Senate Finance Committee's release of additional PBM reform legislation and the Committee's markup scheduled for Wednesday, November 8, NACDS President & CEO Steven C. Anderson released the following statement:

"NACDS' message is clear: real PBM reform at the federal level must protect Americans on Medicare and Medicaid and their pharmacies. We commend the Senate Finance Committee's bipartisan work to deliver on this unique moment of opportunity to reduce patient's prescription drug costs, to defend patients' access to medications and to pharmacies, and to confront abusive PBM tactics that jeopardize all Americans and all pharmacies. We look forward to continuing to work with the Committee and with the Congress to ensure the effectiveness of this legislation in achieving their well-focused intent.

"NACDS urges Congress to continue to stand strong on a bipartisan basis to confront the middlemen's 'pharmaceutical benefit manipulation' in healthcare and in the legislative process. Past is prologue, and the PBMs will attack and complicate this straightforward and necessary legislation in predictable and misleading ways. For all Americans and for all pharmacies, Congress cannot allow the derailing ? or the sabotage ? of necessary reforms.

"The legislation to be considered this Wednesday complements aspects of the Modernizing and Ensuring PBM Accountability Act passed previously by the Committee. Together, the two bills include the Medicaid reforms in the NACDS-backed Protect Patient Access to Pharmacies Act; the Medicare reforms in the NACDS-backed Neighborhood Options for Patients Buying Medicines Act ? including the must-have ability to ensure 'reasonable and relevant' PBM contract terms in Medicare; provisions for strong CMS enforcement; as well as provisions related to Medicare quality measures and transparency.

"Further, it is imperative that the Committee and the Congress stay focused on preventing the 'pharmaceutical benefit manipulation' that middlemen achieve by blasting through loopholes in legislation and regulation. NACDS will continue to work with the Committee and with the Congress to identify and prevent well-intended policies that could lead to further manipulation by the PBMs, which harms Americans and pharmacies of all types and sizes."

NACDS currently is advertising on the vital theme of "real reform."

Media Contact
Kathleen Bashur, NACDS, 703-837-4367, [email protected], https://www.nacds.org/

SOURCE NACDS